Source:http://linkedlifedata.com/resource/pubmed/id/18383187
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-10-21
|
pubmed:abstractText |
We report here a patient with relapsed follicular lymphoma who developed secondary acute myeloid leukaemia 15 months after radioimmunotherapy (RIT) with (90)Y-ibritumomab tiuxetan, the fifth described case to date. We review the literature for the potential causal relationship between RIT and secondary myelodysplastic syndromes/acute myeloid leukaemia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0278-0232
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2008 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
179-81
|
pubmed:meshHeading |
pubmed-meshheading:18383187-Antibodies, Monoclonal,
pubmed-meshheading:18383187-Female,
pubmed-meshheading:18383187-Humans,
pubmed-meshheading:18383187-Leukemia, Myeloid, Acute,
pubmed-meshheading:18383187-Lymphoma, Follicular,
pubmed-meshheading:18383187-Middle Aged,
pubmed-meshheading:18383187-Neoplasms, Second Primary,
pubmed-meshheading:18383187-Radioimmunotherapy,
pubmed-meshheading:18383187-Yttrium Radioisotopes
|
pubmed:year |
2008
|
pubmed:articleTitle |
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma.
|
pubmed:affiliation |
Division of Hematology, Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Italy. focosi@icgeb.org
|
pubmed:publicationType |
Journal Article,
Case Reports
|